913 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B N/A
Article Searches
The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo http://www.zacks.com/stock/news/409269/the-zacks-analyst-blog-highlights-merck-pfizer-abbvie-sanofi-and-glaxo?cid=CS-ZC-FT-409269 May 06, 2019 - The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo
Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod http://www.zacks.com/stock/news/408311/pharma-stock-roundup-mrk-lly-pfe-report-q1-earnings-sny-abbv-drugs-get-eu-nod?cid=CS-ZC-FT-408311 May 03, 2019 - Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.
Dow 30 Stock Roundup: AAPL, PFE, MRK, MCD Earnings Impress http://www.zacks.com/stock/news/408282/dow-30-stock-roundup-aapl-pfe-mrk-mcd-earnings-impress?cid=CS-ZC-FT-408282 May 03, 2019 - The index traversed a mixed week, buoyed by encouraging earnings numbers and dragged lower by comments from the Fed Chair.
Are You Looking for a High-Growth Dividend Stock? Merck (MRK) Could Be a Great Choice http://www.zacks.com/stock/news/407489/are-you-looking-for-a-high-growth-dividend-stock-merck-mrk-could-be-a-great-choice?cid=CS-ZC-FT-407489 May 02, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.
Company News For May 1, 2019 http://www.zacks.com/stock/news/406426/company-news-for-may-1-2019?cid=CS-ZC--406426 May 01, 2019 - Companies in the news are: GE, GM, MRK and MA
Merck & Co Inc (MRK) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/04/30/merck-co-inc-mrk-q1-2019-earnings-call-transcript.aspx?source=iedfolrf0000001 Apr 30, 2019 - MRK earnings call for the period ending March 31, 2019.
Merck & Co Inc. (MRK) CEO Ken Frazier on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4258153-merck-and-co-inc-mrk-ceo-ken-frazier-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare Apr 30, 2019 - Merck & Co Inc. (NYSE:MRK) Q1 2018 Earnings Conference Call April 30, 2019 8:00 AM ET Company Participants Teri Loxam - SVP, Investor Relations and Global Communications Ken Frazier - Chairman and
Merck (MRK) Tops on Q1 Earnings & Sales, Stock Up http://www.zacks.com/stock/news/405495/merck-mrk-tops-on-q1-earnings-sales-stock-up?cid=CS-ZC-FT-405495 Apr 30, 2019 - Merck (MRK) beats estimates for earnings as well as sales in first-quarter 2019. Stock is up in pre-market trading.
AstraZeneca's (AZN) Q1 Earnings Beat, New Drugs Drive Sales http://www.zacks.com/stock/news/404479/astrazenecas-azn-q1-earnings-beat-new-drugs-drive-sales?cid=CS-ZC-FT-404479 Apr 26, 2019 - AstraZeneca (AZN) beats earnings and sales estimates in the first quarter. New drugs, especially cancer drugs, drive revenues.
Kidney-Cancer Market: Good for Patients, Hard for Investors https://www.fool.com/investing/2019/04/23/kidney-cancer-market-good-for-patients-hard-for-in.aspx?source=iedfolrf0000001 Apr 23, 2019 - Drugmakers battle for patients.

Pages: 1...678910111213141516...92

<<<Page 11>